Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries
Breast and cervical cancers have emerged as major global health challenges and disproportionately lead to excess morbidity and mortality in low- and middle-income countries (LMICs) when compared to high-income countries. The objective of this paper was to highlight key findings, recommendations, and...
Saved in:
Published in: | PloS one Vol. 10; no. 9; p. e0134618 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Public Library of Science
01-09-2015
Public Library of Science (PLoS) |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Breast and cervical cancers have emerged as major global health challenges and disproportionately lead to excess morbidity and mortality in low- and middle-income countries (LMICs) when compared to high-income countries. The objective of this paper was to highlight key findings, recommendations, and gaps in research and practice identified through a scoping study of recent reviews in breast and cervical cancer in LMICs.
We conducted a scoping study based on the six-stage framework of Arskey and O'Malley. We searched PubMed, Cochrane Reviews, and CINAHL with the following inclusion criteria: 1) published between 2005-February 2015, 2) focused on breast or cervical cancer 3) focused on LMIC, 4) review article, and 5) published in English.
Through our systematic search, 63 out of the 94 identified cervical cancer reviews met our selection criteria and 36 of the 54 in breast cancer. Cervical cancer reviews were more likely to focus upon prevention and screening, while breast cancer reviews were more likely to focus upon treatment and survivorship. Few of the breast cancer reviews referenced research and data from LMICs themselves; cervical cancer reviews were more likely to do so. Most reviews did not include elements of the PRISMA checklist.
Overall, a limited evidence base supports breast and cervical cancer control in LMICs. Further breast and cervical cancer prevention and control studies are necessary in LMICs. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Competing Interests: Dr. Smith reports grants and personal fees from Merck, grants from GlaxoSmithKline, personal fees from Hologic, grants from Trovagene, outside the submitted work. Mr. Fogg reports grants from Centers for Disease Control and Prevention, during the conduct of the study. Dr. Dye reports grants from Centers for Disease Control and Prevention, during the conduct of the study; grants from National Institutes of Health, grants from Pfizer, personal fees from Humana, outside the submitted work. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials. Conceived and designed the experiments: MD KP JAD AD HN SM JSS AS TI TF MK RB MM TD. Performed the experiments: AD JAD KP MK MD TD TI TF. Analyzed the data: JAD JSS KP AS MK SM AD HN MD TD TF RB MM. Wrote the paper: MD TD. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0134618 |